Tuesday, December 22, 2020

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe The company#39;s product is a novel fixed-dose combination nasal spray of an antihistamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age.

from Moneycontrol Business News https://ift.tt/3rm6pYi
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...